Navigation Links
Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook
Date:2/20/2008

for income taxes 119.7 127.1

Depreciation (includes accelerated

depreciation) 95.6 95.6

Amortization 80.8 80.8

EBITDA 507.0 527.0

Adjusted for:

Global supply chain initiative 23.4 23.4

Share-based compensation 16.7 16.7

Licensing charges 6.0 6.0

Loss on early extinguishment of debt 1.9 1.9

Adjusted EBITDA $555.0 $575.0

The reconciliation table is based in part on management's estimate of adjusted EBITDA for the year ending December 31, 2008. Watson expects certain known GAAP charges for 2008, as presented in the schedule above. Other GAAP charges that may be excluded from estimated EBITDA are possible, but their amounts are dependent on numerous factors that we currently cannot ascertain with sufficient certainty or are presently unknown. These GAAP charges, such as potential asset impairment charges, are dependent upon future events and valuations that have not yet been performed.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO)


'/>"/>
SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Watson to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
2. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
3. Watson Receives FDA Approval for Generic Accuneb(R)
4. Watson to Present at the Bear Stearns 20th Annual Healthcare Conference
5. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
6. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
7. Boehringer Ingelheim Pharmaceuticals, Inc. Receives the NCQA Seal Of Approval
8. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar and Report Full Year 2007 Financial Results
9. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
10. Keryx Biopharmaceuticals Announces Additions to Management Team
11. Cadence Pharmaceuticals to Raise up to $49.3 Million in Registered Direct Common Stock Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... University (NTU) signed the Memorandum of Understanding in ... (CNRS) and the Thales Group of Companies to ... parties are meeting again in Singapore to inaugurate ... , Located at the Research Techno Plaza, ... in science and technology to develop innovations in ...
(Date:12/16/2009)... LAS VEGAS, Dec. 16 Cord Blood ... cord blood stem cell preservation company ( http://www.cordblood-america.com ... potential of stem cells, a biological insurance policy, ... it has reduced its debt by a total ... quarter of 2009 and total debt eliminated for ...
(Date:12/16/2009)... Protocol Assessment with the Food and Drug ... - AEterna Zentaris Inc. (NASDAQ: AEZS ... biopharmaceutical company focused on oncology and endocrine ... partner Keryx Biopharmaceuticals Inc. ("Keryx") ( KERX), ... for perifosine (KRX-0401), the Company,s PI3K/Akt pathway ...
(Date:12/15/2009)... MARINO, Calif., Dec. 15 Epeius Biotechnologies ... targeted genetic medicine, gained international validation of the ... Rexin-G , when scientists around the world rediscovered ... a major locus of cancer pathogenesis and disease ... therapies. Recently, scientists at the NIH National Cancer ...
Breaking Biology Technology:New Singapore-French nanotech lab opens at NTU 2New Singapore-French nanotech lab opens at NTU 3Cord Blood America Says 2009 Debt Reduction Tops $10 Million 2Cord Blood America Says 2009 Debt Reduction Tops $10 Million 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3
... InterMune, Inc.,(Nasdaq: ITMN ) today announced that Daniel ... at the Canaccord Adams 28th Annual,Global Growth Conference in ... To access a live audio webcast of the ... the investor relations page of InterMune,s,corporate website at ...
... 7 Medicsight PLC, a subsidiary,of MGT Capital ... industry leader in the,development of Computer-Aided Detection (CAD) ... received approval from the Brazilian regulatory,agency, Agencia Nacional ... David Sumner, Chief Executive of Medicsight, commented: "This ...
... Sciences and Photonics, today announced that its analytical solutions are ... Monitoring (BFSM) in a mobile laboratory supporting the Beijing Games. ... organic compounds in beverages and pesticides in food products. ... ...
Other Biology Technology:Medicsight Receives Brazilian State Food and Drug Administration Approval for ColonCAD Software 2Medicsight Receives Brazilian State Food and Drug Administration Approval for ColonCAD Software 3 PerkinElmer Expertise and Solutions Integral to Food Safety Monitoring for the Beijing Games : Methods, Applications Expertise and Instrumentation Deployed in Mobile Laboratory 2 PerkinElmer Expertise and Solutions Integral to Food Safety Monitoring for the Beijing Games : Methods, Applications Expertise and Instrumentation Deployed in Mobile Laboratory 3
(Date:12/16/2009)... and PALM HARBOR, Fla., Dec. 2 /PRNewswire-FirstCall/ ... Board: CICI), a leading supplier of electronic ... the financial industry* and the recognized leader** ... Inc. ("Docubase"), a leading International Electronic Document ... they have entered an agreement to provide ...
(Date:12/16/2009)... Inc. is pleased to announce it has acquired ... operating as IgeaCare Systems Inc. The newly formed ... leadership and funding. ,, IgeaCare Solutions Inc. has ... Chief Executive Officer. Under his direction, the new ... and support model; fast and accurate delivery times; ...
(Date:12/16/2009)... BIO-key International, Inc. (OTC Bulletin Board: BKYI), ... today announced that SC Magazine, one of ... BIO-key International the 2009 Innovator of the ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20050509/BIOKEYLOGO ) ,, ... Magazine, "Biometric providers have been trying for ...
Breaking Biology News(10 mins):CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4IgeaCare Solutions Inc. Emerges Under New Leadership and Funding 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 3CardioGenics Holdings Inc Engages Gilford Securities As Investment Banker 14339 1CardioGenics Holdings Inc Engages Gilford Securities As Investment Banker 14339 2Dental Plaque Buildup May Raise Heart Risk in Black Men 58791 1Dental Plaque Buildup May Raise Heart Risk in Black Men 58791 2Einstein to develop anti HIV drug delivery system 10245 1Einstein to develop anti HIV drug delivery system 10245 2Einstein to develop anti HIV drug delivery system 10245 3
... Dean of the Watson School of Biological Sciences, has ... , Dr. Joshua-Tor, a structural biologist whose ... 56 new HHMI Investigators selected from among 1,070 applicants. ... program, who lead Hughes laboratories at 64 institutions. ...
... found that consuming cocoa flavanols naturally occurring compounds ... affected by type-2 diabetes. , Consuming a cocoa ... impact the blood vessel dysfunction associated with diabetes, suggests ... the American College of Cardiology by an international group ...
... of southern England are too hot to grow vines for ... today (26 May 2008). , The author, Emeritus Professor ... summer temperatures in the UK continue to rise as predicted, ... which currently contain many vineyards, will be too hot to ...
Other Biology News:Leemor Joshua-Tor, PhD, CSHL biologist and WSBS dean, is named an HHMI Investigator 2Leemor Joshua-Tor, PhD, CSHL biologist and WSBS dean, is named an HHMI Investigator 3 Natural compounds in cocoa tied to blood flow improvements for adults with type 2 diabetes 2 Natural compounds in cocoa tied to blood flow improvements for adults with type 2 diabetes 3 Natural compounds in cocoa tied to blood flow improvements for adults with type 2 diabetes 4Research suggests parts of UK could be too hot for wine-making by 2080 2
100 adhesive strips....
Homo sapiens palladin...
Mouse P-Selectin/CD62P MAb (Clone 127933)...
Molecular Biological Resources has extensive abilities cloning and expression of prokaryotic and eukaryotic proteins. Please contact lloconne@molbiores.com to discuss your project. Contact lloconne@...
Biology Products: